Truist lowered the firm’s price target on Humana (HUM) to $200 from $285 and keeps a Hold rating on the shares. The firm is adjusting its model after the company’s Q4 results and guidance.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana price target lowered to $173 from $260 at TD Cowen
- Humana price target lowered to $180 from $231 at Deutsche Bank
- Balanced Risk-Reward Amid Growth Ambitions and Margin Rebuild Supports Humana Hold Rating
- Midday Fly By: Cisco reports Q2 beat, Trump orders Pentagon to buy coal
- Shopify upgraded, Coinbase downgraded: Wall Street’s top analyst calls